QuidelOrtho Corp. Hits Day Low at $14 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock declining by 7.64% as it reached an intraday low of USD 14.00. This drop is part of a broader trend, as the company has reported negative performance metrics over various time frames. In the past week, QuidelOrtho's stock has fallen by 17.97%, and over the past month, it has seen a decline of 28.75%. Year-to-date, the stock is down 50.46%, and its performance over the last year shows a staggering decrease of 50.95%. The three-year performance reflects an even more pronounced decline of 84.29%, while the five-year performance stands at a loss of 88.51%. The company's financial health is concerning, with a debt-equity ratio of 138.72% and a low interest coverage ratio of 142.31. Additionally, QuidelOrtho has reported negative results for the last 12 consecutive quarters, indicating ongoing challenges in its operational performance. The stock's price-to-book ratio is currently at 0.63, further highlighting its struggles in the market.